Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Silvia Spinazzé"'
Autor:
Gianmauro Numico, Antonella Cristofano, Alessandro Mozzicafreddo, Olga Elisabetta Cursio, Pierfrancesco Franco, Giulia Courthod, Antonio Trogu, Alessandra Malossi, Mariella Cucchi, Zuzana Sirotovà, Maria Rosa Alvaro, Anna Stella, Fulvia Grasso, Silvia Spinazzé, Nicola Silvestris
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120827 (2015)
Cancer patients are frequently admitted to hospital due to acute conditions or refractory symptoms. This occurs through the emergency departments and requires medical oncologists to take an active role. The use of acute-care hospital increases in the
Externí odkaz:
https://doaj.org/article/a43594bf0b8d407faf61a04ac320096b
Autor:
Cesare Grandi, Roberto Molinari, Esteban Cvitkovic, Jacques Bernier, Paolo Bruzzi, Lisa Licitra, Silvia Spinazzé, Gemma Gatta
Publikováno v:
Critical Reviews in Oncology/Hematology. 45:199-214
Nasopharyngeal cancer (NPC) is quite rare throughout Europe, accounting for an annual incidence rate below 1 per 100.000, whereas the highest risk area is South East Asia. A predominant occurrence in males is to be noted. NPC is an etiologically mult
Autor:
Olga Elisabetta Cursio, Fulvia Grasso, Silvia Spinazzé, Alessandra Malossi, Zuzana Sirotovà, Pierfrancesco Franco, Nicola Silvestris, Anna Stella, Mariella Cucchi, Maria Rosa Alvaro, Antonio Trogu, Alessandro Mozzicafreddo, Gianmauro Numico, Giulia Courthod, Antonella Cristofano
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120827 (2015)
PLoS ONE
PLoS ONE
Background Cancer patients are frequently admitted to hospital due to acute conditions or refractory symptoms. This occurs through the emergency departments and requires medical oncologists to take an active role. The use of acute-care hospital incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d991d9a9e8427f33ace9a47bb3881f
http://hdl.handle.net/2318/1524093
http://hdl.handle.net/2318/1524093
Publikováno v:
Critical Reviews in Oncology/Hematology. 43:93-101
The emetogenic potential of cancer chemotherapeutic agents varies according to the agent employed. Among the highly emetogenic agents, cisplatin has been the most studied. As for emesis induced by cisplatin, an optimal antiemetic schedule is effectiv
Autor:
Gianmauro Numico, F. Migliaccio, Umberto Ricardi, Pierfrancesco Franco, Maria Rosa La Porta, Silvia Spinazzé, Antonella Cristofano, Piera Sciacero, Domenico Cante, Franco Girelli, Nicola Silvestris
The administration of Cetuximab in combination with radiotherapy and chemotherapy has shown clear survival improvements within the locally advanced and the relapsed/metastatic settings respectively. These results have provided the clinical rational f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757a7c8188a34024d394a249ae2d8180
http://hdl.handle.net/2318/116513
http://hdl.handle.net/2318/116513
Publikováno v:
Critical reviews in oncology/hematology. 56(3)
Spinal cord compression from epidural metastases (epidural spinal cord compression, ESCC) is the most common neurological complication of cancer after brain metastases. Extradural compression represents 97% of spinal cord metastatic lesions. ESCC usu
Autor:
Paolo Bidoli, Amedeo Vittorio Bedini, Armando Santoro, Paolo G. Casali, Adalgiso Guzzon, Silvia Spinazzé
Publikováno v:
Scopus-Elsevier
Twenty-five patients with advanced non-small-cell lung carcinoma (NSCLC) were treated with a multidrug regimen (CIV) consisting of ifosfamide (IFX), cisplatin (CDDP), and etoposide (VP-16). Twenty-four patients were evaluable for response. An objecti
Autor:
Simonetta Viviani, Giorgio Parmiani, Peter A. Palmer, Christopher R. Franks, Licia Rivoltini, Silvia Spinazzé, Franco Rovelli, Paolo Bidoli, Flavio Arienti
Publikováno v:
ResearcherID
Scopus-Elsevier
Scopus-Elsevier
Interleukin-2 has been shown to stimulate Cortisol secretion in man. Owing to its Immunosuppressive properties, an increase in Cortisol levels during interleukin-2 cancer immunotherapy could potentially counteract induced activation of the antitumor
Autor:
Lisa Licitra, Silvana Marchini, Andrea Rocca, Anna Rossi, Cesare Grandi, Roberto Molinari, Silvia Spinazzé
Publikováno v:
Cancer. 68(9)
A prospective Phase II study was carried out to test cisplatin (CDDP) as a single agent in salivary gland carcinomas. CDDP was administered (100 mg/m2) every 3 weeks to 25 consecutive patients with either recurrent or locally advanced salivary gland
Autor:
Ignazio Cataldo, Silvia Spinazzé, Amedeo Vittorio Bedini, Armando Santoro, Paolo Bidoli, Gianni Bonadonna
Publikováno v:
Tumori Journal. 75:34-37
Twenty-one patients with limited (12 cases) or extensive (9 cases) small cell lung cancer entered a pilot study with adriamycin (ADM) plus ifosfamide (IFX) as first line treatment for six planned cycles. ADM was administered at the dose of 60 mg/m2 i